mda-mb-468 glutathione content Using a novel panel of drug-resistant triple-negative breast cancer cell lines to identify candidate therapeutic targets and biomarkers Frontiers | Formononetin triggers ferroptosis
Frontiers Formononetin triggers ferroptosis in triple negative breast cancer cells by regulating the mTORC1 SREBP1 SCD1 pathway MDA MB 468 AcceGen Anticancer Effects of Thymoquinone through the Antioxidant Activity, Upregulation of Nrf2, and Downregulation of PD L1 in Triple Negative Breast Cancer Cells Auranofin Suppresses Cancer Cell Invasion by Inhibiting Heparanase 1 Expression via the aPKCNF B Pathway MDA MB 468 an overview ScienceDirect Topics
Pay in 4 interest-free payments of $7.05 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




